Aurobindo Pharma informs about press release

29 Nov 2023 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by the Company, for Darunavir Tablets, 600 mg and 800 mg.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×